Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 34 | 39 | +5 |
| Shares | 624.4K | 1.72M | +1.10M (+175.6%) |
| Value | $773.2K | $1.34M | +$563.7K (+72.9%) |
New holders (9)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Heights Capital Management, Inc | 799,934 | $621.5K | 0.24% |
| Asset Advisory Group, Inc. | 59,011 | $45.9K | 0.02% |
| Two Sigma Securities, LLC | 28,578 | $22.2K | 0.00% |
| LPL Financial LLC | 25,067 | $19.5K | 0.00% |
| Scientech Research LLC | 20,904 | $16.2K | 0.01% |
| Tower Research Capital LLC (TRC) | 2,808 | $2.18K | 0.00% |
| Curio Wealth, LLC | 2,000 | $1.60K | 0.00% |
| Harbour Investments, Inc. | 50 | $39 | 0.00% |
| TD Waterhouse Canada Inc. | 4 | $3 | 0.00% |
Sold out (4)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 10,044 | $12.0K |
| Simplex Trading, LLC | 9,556 | $11.0K |
| Legacy Wealth Managment, LLC | 930 | $1.15K |
| Farther Finance Advisors, LLC | 343 | $425 |